GeRI Remote Monitoring Study: 10 Prostate Cancer Patients Over 12 Weeks

This dataset documents a 12-week in-home deployment of the GeRI platform for remote symptom assessment and activity monitoring among 10 men aged 65+ receiving androgen deprivation therapy for prostate cancer. It captures engagement metrics, usability scores, and wearable-derived activity data.

Use Cases

• Analyze the correlation between comorbidity/polypharmacy status and lower activity metrics like steps and cadence.
• Model engagement thresholds by comparing participant completion rates for surveys, scale readings, and watch session initiation prompts.
• Explore the relationship between self-rated health/symptom survey triggers and subsequent 48-hour accelerometry windows.
• Assess the validity of wearable data by examining criteria for 24-hour intervals, such as non-wear time and daily step count.

Strengths

• Data from a 12-week home deployment provides longitudinal monitoring context.
• Engagement was high, with 9 out of 10 participants meeting prespecified interaction completion thresholds in all three 4-week blocks.
• Usability was assessed with the System Usability Scale, with scores ranging from 57.5 to 100.

Limitations

• Small sample size of 10 participants limits statistical power and generalizability.
• One participant contributed 0 valid wearable data intervals despite initiating all prompts, indicating potential data collection issues.
• The dataset's primary format is a DOCX document, which may require significant extraction and structuring for quantitative analysis.

Provenance

Source

figshare, author Nabiel Mir.

Collection Method

Data collected during a 12-week home deployment study evaluating the GeRI platform, integrating a wrist-worn accelerometer, smart scale, and tablet interface.

Time Range

Study duration of 12 weeks.

Freshness

Last updated 2026-03-20.